Correlation Between Ubiquitech Software and OWC Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Ubiquitech Software and OWC Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ubiquitech Software and OWC Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ubiquitech Software and OWC Pharmaceutical Research, you can compare the effects of market volatilities on Ubiquitech Software and OWC Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ubiquitech Software with a short position of OWC Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ubiquitech Software and OWC Pharmaceutical.

Diversification Opportunities for Ubiquitech Software and OWC Pharmaceutical

-0.11

Correlation Coefficient

Ubiquitech Software  OWC Pharmaceutical

Good diversification

The 3 months correlation between Ubiquitech and OWC is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Ubiquitech Software and OWC Pharmaceutical Research in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OWC Pharmaceutical and Ubiquitech Software is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ubiquitech Software are associated (or correlated) with OWC Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OWC Pharmaceutical has no effect on the direction of Ubiquitech Software i.e., Ubiquitech Software and OWC Pharmaceutical go up and down completely randomly.

Pair Corralation between Ubiquitech Software and OWC Pharmaceutical

Given the investment horizon of 90 days Ubiquitech Software is expected to generate 1.92 times more return on investment than OWC Pharmaceutical. However, Ubiquitech Software is 1.92 times more volatile than OWC Pharmaceutical Research. It trades about 0.33 of its potential returns per unit of risk. OWC Pharmaceutical Research is currently generating about 0.16 per unit of risk. If you would invest  0.01  in Ubiquitech Software on October 10, 2024 and sell it today you would lose (0.01) from holding Ubiquitech Software or give up 100.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Ubiquitech Software  vs.  OWC Pharmaceutical Research

Ubiquitech Software

Risk-Adjusted Performance

26 of 100

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in Ubiquitech Software are ranked lower than 26 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Ubiquitech Software unveiled solid returns over the last few months and may actually be approaching a breakup point.

OWC Pharmaceutical

Risk-Adjusted Performance

0 of 100

Good

Over the last 90 days OWC Pharmaceutical Research has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively weak fundamental indicators, OWC Pharmaceutical reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Ubiquitech Software and OWC Pharmaceutical

The main advantage of trading using opposite Ubiquitech Software and OWC Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ubiquitech Software position performs unexpectedly, OWC Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OWC Pharmaceutical will offset losses from the drop in OWC Pharmaceutical's long position.

The idea behind Ubiquitech Software and OWC Pharmaceutical Research pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.